ScyFIX work regarding MCS and treatment of Macular Degeneration

The following summary of the research on the use of microcurrent stimulation in the treatment of retinal disease is from the company ScyFIX, and was part of their submission to the FDA in an attempt to gain approval for a clinical trial that would allow them to market a unit for eye treatment.
 
They refer to studies done as part of this submission to the FDA, but these were never published. ScyFIX became Acuity Medical, and was eventually sold to a company named “The Eye Machine”. As of 2016, they have still not been able to gain FDA approval to proceed with any clinical trials. ScyFIX did have a unit approved for use in Europe, but it seems to be currently out of production.

NOTE: Click on the image of the article to open it in another window where you can read it online. Some files may not be available for download for copyright reasons.


About the author

Carlyle Coash